In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indometicina Drug Master File in Korea (Indometicina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indometicina. The MFDS reviews the Indometicina KDMF as part of the drug registration process and uses the information provided in the Indometicina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indometicina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indometicina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indometicina suppliers with KDMF on PharmaCompass.